Sclerostin （SOST）ELISA 检测试剂盒 Cat.No.:BI-20492 应用领域：
1）肾病检测 2）肿瘤诱导的骨病 3）代谢病治疗的疗效监测，例如：甲状旁腺治疗的监测。 4）风湿性关节炎 5）骨质疏松症 试剂盒特点： 检测方法：夹心ELISA,HRP/TMB显色系统 样本类型：血清、血浆（EDTA或肝素抗凝）、尿样（参照对应的protocol） 样品量：20ul/test 标准品范围：0-240 pmol/L 检测灵敏度：2.6pmol/L 孵育条件：overnigh/1小时/30分钟（室温） 单位转换：1pg/ml=0.044pmol 参考文献：Sclerostin与肾病、糖尿病、心脏主动脉瓣硬化患者的关系。 Sclerostin: another bone-related protein related to all-cause mortality in haem dialysis? Viaene L et al., Nephrol Dial Transplant, 2013; 10.1093/ndt/gft039 | The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD. Pelletier S et al., Clin J Am Soc Nephrol, 2013; 8: 819-823 | Sclerostin and DKK-1 levels in pre-dialyisis CKD patients. Behets G et al., Nephrol Dial Transplant, 2012; 27: ii36-ii37 | Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Cejka D et al., Nephrol Dial Trans-plant, 2012; 27: 226-230 | Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus. Gaudio A et al., J Clin Endocrinol Metab, 2012; 97: 3744–3750 | Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes. Gennari L et al., J Clin Endo Metab, 2012; 97: 1737-1744 | Association of Sclerostin levels with the severity of aortic valve calcification. Koos et al., JACC, 2011; 57, 14 | Serum Sclerostin levels are associated with aortic valve calcification in prevalent ha-emodialysis patients. Türkvatan A et al., Nephrol Dial Transplant, 2013; 28: i19–i21 | Circulating Sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Thambiah S et al., Calcif Tissue Int, 2012; 90(6): 473-480 |
|
